FMO3 and Huntington disease: Regarding this, Pelletier et al. demonstrated that four hours of hemodialysis significantly reduced the TMAO plasma levels, raising the hypothesis that HD patients may increase the production of TMAO through the liver enzyme FMO3 and prefer the TMAO production pathway over urea [23].